uniQure N.V [QURE] stock is trading at $7.16, up 18.15%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The QURE shares have gain 13.56% over the last week, with a monthly amount glided 20.95%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Goldman downgraded its rating to Neutral on February 29, 2024, and kept the price target unchanged to $8. On December 19, 2023, downgrade downgraded it’s rating to Neutral and revised its price target to $10 on the stock. UBS upgraded its rating to a Buy but stick to its price target of $40 on March 17, 2022. BTIG Research initiated its recommendation with a Buy and recommended $46 as its price target on June 15, 2021. UBS started tracking with a Neutral rating for this stock on May 21, 2021, and assigned it a price target of $40.
uniQure N.V [QURE] stock has fluctuated between $3.73 and $11.35 over the past year. Currently, Wall Street analysts expect the stock to reach $53.67 within the next 12 months. uniQure N.V [NASDAQ: QURE] shares were valued at $7.16 at the most recent close of the market. An investor can expect a potential return of 649.58% based on the average QURE price forecast.
Analyzing the QURE fundamentals
uniQure N.V [NASDAQ:QURE] reported sales of 28.59M for the trailing twelve months, which represents a growth of 62.54%. Gross Profit Margin for this corporation currently stands at -0.09% with Operating Profit Margin at -7.16%, Pretax Profit Margin comes in at -8.22%, and Net Profit Margin reading is -8.38%. To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is -1.89 and Total Capital is -0.36. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.44 points at the first support level, and at 5.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.58, and for the 2nd resistance point, it is at 8.00.
Ratios To Look Out For
For context, uniQure N.V’s Current Ratio is 6.51. Also, the Quick Ratio is 6.51, while the Cash Ratio stands at 3.53. Considering the valuation of this stock, the price to sales ratio is 12.20, the price to book ratio is 6.25.
Transactions by insiders
Recent insider trading involved Abi-Saab Walid, Chief Medical Officer, that happened on Jun 26 ’24 when 1447.0 shares were sold. Chief Operating Officer, CALOZ PIERRE completed a deal on Jun 17 ’24 to sell 2936.0 shares. Meanwhile, Chief Financial Officer KLEMT CHRISTIAN sold 1611.0 shares on Jun 17 ’24.
